hepatitis a virus, strain cr326f inactivated

Poland

Drugs containing this active substance

  • VAQTA 25

    The vaccine is used to immunize the body against infections caused by hepatitis A virus.

    Form: suspension for injection

    Active substance Dosage
    hepatitis a virus, strain cr326f inactivated 25 U

    ATC: J07BC02

    Manufacturer: Merck Sharp & Dohme B.V.

  • VAQTA 50

    The vaccine is used to immunize the body against infections caused by the hepatitis A virus. It is recommended for healthy adults (18 years and older) who are at risk of infection or for whom the disease may be life-threatening (e.g., individuals with HIV or hepatitis C).

    Form: suspension for injection

    Active substance Dosage
    hepatitis a virus, strain cr326f inactivated 50 U

    ATC: J07BC02

    Manufacturer: Merck Sharp & Dohme B.V.